Ratings Summary for DOSTINEX
Overall Patient opinion of DOSTINEX: 3.5 (satisfied)
(based on 434 reviews ) (updated May 6, 2025)Ratings by Age Group for DOSTINEX
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Age Group | Number of Reviews | Average Rating |
|---|---|---|
| Pediatric (Under 18) | 6 | 3 |
| Age 18 to 24 | 40 | 3.6 |
| Age 25 to 34 | 143 | 3.6 |
| Age 35 to 44 | 138 | 3.4 |
| Age 45 to 54 | 63 | 3.6 |
| Age 55 to 64 | 31 | 3.9 |
| Age 65 to 74 | 4 | 3.2 |
| Age 75 and up | 1 | 5 |
Ratings by Sex for DOSTINEX
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Sex | Number of Reviews | Average Rating |
|---|---|---|
| Male | 119 | 3.61344537815126 |
| Female | 309 | 3.47249190938511 |
| Not Specified | 6 | 3.33333333333333 |
Would you like to find reviews for DOSTINEX taken for a specific reason or resulting in a specific side effect?
Filter Results for DOSTINEX
FDA Drug Safety Information for DOSTINEX
Check here for Ask a Patient's Adverse Event Summary for DOSTINEX based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.
DOSTINEX (CABERGOLINE): This medication is used to treat high levels of prolactin hormone in your body. High levels of prolactin in women can cause symptoms such as unwanted breast milk and missed periods and can cause difficulty becoming pregnant. High levels of prolactin in men can cause symptoms such as enlarged breasts and decreased sexual ability/desire. Cabergoline is an ergot medication and works by blocking the release of prolactin from the pituitary gland. FDA Approval Date: 1996-12-23 (Sources: U.S. Centers for Medicare Services, FDA)
